Related Experiment Video
Updated: Mar 7, 2026

11:37
QTL Mapping and CRISPR/Cas9 Editing to Identify a Drug Resistance Gene in Toxoplasma gondii
Published on: June 22, 2017
16.9K
Transcriptome-based SNP discovery by GBS and the construction of a genetic map for olive
Ahmet İpek1, Meryem İpek2, Sezai Ercişli3
1Faculty of Agriculture, Horticulture Department, Uludag University, Bursa, Turkey. maipek@uludag.edu.tr.
Functional & Integrative Genomics
|February 19, 2017
Summary
Researchers developed new SNP markers for olive trees using genotyping-by-sequencing. This advanced genetic map aids in identifying genes for important traits and supports marker-assisted selection in olive breeding.
Area of Science:
- Plant genetics
- Genomics
- Molecular biology
Background:
- Molecular markers are crucial for identifying genes related to economically important plant traits.
- Traditional methods for developing markers like SSRs and SNPs from ESTs are labor-intensive.
Purpose of the Study:
- To develop single-nucleotide polymorphism (SNP) markers within the olive transcriptome using genotyping-by-sequencing (GBS).
- To construct a high-density genetic linkage map for the olive genome.
Main Methods:
- Genotyping-by-sequencing (GBS) was applied to 125 olive DNA samples.
- Illumina sequencing reads were aligned to the olive transcriptome to identify SNPs.
- A genetic linkage map was constructed using identified SNPs, SSRs, and CAPS markers.
Main Results:
- 22,033 transcriptome-based SNP markers were identified.
- 3,384 SNP markers were successfully mapped to the olive genome.
- A saturated genetic linkage map covering 3340.8 cM across 23 linkage groups was generated.
Conclusions:
- The developed genetic map is a valuable resource for localizing quantitative trait loci (QTLs) and candidate genes in olives.
- This map will facilitate marker-assisted selection for improving economically important traits in olive breeding programs.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
19.2K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
19.2K
Genome-wide Association Studies-GWAS
16.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
16.2K
Pharmacogenomics: Identification of New Drug Targets
56
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
56

